- cafead Dec 15, 2023 at 11:42: AM
via Immusoft has administered an engineered B cell to a human for the first time, marking a milestone in its long-running quest to create a new type of medicine.
The West Coast biotech set up shop in 2009 and made headlines five years later when it received money from Tim Draper, a venture capitalist involved with companies from Hotmail to SpaceX, and Peter Thiel’s FF Science. But progress has been slower than hoped. In 2013, then-CEO Matthew Scholz spoke of skipping primate testing and going “directly into humans ... in the next couple of years, hopefully.”
article source
The West Coast biotech set up shop in 2009 and made headlines five years later when it received money from Tim Draper, a venture capitalist involved with companies from Hotmail to SpaceX, and Peter Thiel’s FF Science. But progress has been slower than hoped. In 2013, then-CEO Matthew Scholz spoke of skipping primate testing and going “directly into humans ... in the next couple of years, hopefully.”
article source